A double-blind, randomized, placebo-controlled, single-dose study of the cyclooxygenase-2 inhibitor, GW406381, as a treatment for acute migraine.
about
Oral nonsteroidal anti-inflammatory drugs for neuropathic painNaproxen with or without an antiemetic for acute migraine headaches in adultsPredictive validity of behavioural animal models for chronic painAre the current IHS guidelines for migraine drug trials being followed?Comparative tolerability of treatments for acute migraine: A network meta-analysis.
P2860
A double-blind, randomized, placebo-controlled, single-dose study of the cyclooxygenase-2 inhibitor, GW406381, as a treatment for acute migraine.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
2008年學術文章
@zh
2008年學術文章
@zh-hant
name
A double-blind, randomized, pl ...... treatment for acute migraine.
@en
A double-blind, randomized, pl ...... treatment for acute migraine.
@nl
type
label
A double-blind, randomized, pl ...... treatment for acute migraine.
@en
A double-blind, randomized, pl ...... treatment for acute migraine.
@nl
prefLabel
A double-blind, randomized, pl ...... treatment for acute migraine.
@en
A double-blind, randomized, pl ...... treatment for acute migraine.
@nl
P2093
P2860
P1476
A double-blind, randomized, pl ...... treatment for acute migraine.
@en
P2093
CXA20008 Study Investigators
S K Aurora
T B Jimenez
P2860
P304
P356
10.1111/J.1468-1331.2008.02093.X
P577
2008-02-26T00:00:00Z